SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 17,
(Exact name of registrant as specified in its charter)
|(State or Other Jurisdiction of
|(Commission File Number)||(IRS Employer Identification No.)|
(Address of Principal Executive Offices; Zip Code)
(Registrant’s telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
|Title of each class:||Trading Symbol(s):||Name of each exchange on which registered:|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 11, 2021, the Board of Directors (the “Board”) of Assertio Holdings, Inc. (the “Company”) promoted Paul Schwichtenberg, the Company’s Vice President, Finance since April 2018, to the executive officer role of Senior Vice President, Chief Financial Officer. Mr. Schwichtenberg (50) joined the Company in April 2018 as Vice President, Finance. Prior to joining the Company, he served as Director of Pricing and Planning for AbbVie, a biopharmaceutical company, from October 2013 to April 2018 where he led the U.S. Commercial Pricing Team. Prior to this, Mr. Schwichtenberg served as Controller for Radio Flyer, Inc., a consumer products company, from October 2010 to October 2013. From 2000 to October 2010, Mr. Schwichtenberg served at Takeda Pharmaceuticals in various roles of increasing responsibility, most recently as Senior Director and Controller. Prior to entering the pharmaceutical industry, he served as a senior auditor at Wolf & Company LLP. Mr. Schwichtenberg holds a B.S. degree in Business Administration from Roosevelt University and is a certified public accountant (CPA).
On March 11, 2021, the Board promoted Ajay Patel, the Company’s Vice President, Controller since July 2019, to the executive officer role of Senior Vice President, Chief Accounting Officer. Mr. Patel (37) joined the Company in July 2019 as Vice President, Controller. Prior to joining the Company, from February 2018 to July 2019 he served as Director, Technical Accounting & Accounting Policy at US Foods, a foodservice distributor. From June 2006 to February 2018, Mr. Patel served at Ernst & Young in various roles of increasing responsibility in its Assurance practice leading financial statement audits of strategic key clients. Mr. Patel holds a B.S. degree in Finance from the University of Illinois, a Master’s degree in accounting from the University of Virginia and is a certified public accountant (CPA).
Effective upon Messrs. Schwichtenberg and Patel’s promotions, Daniel A. Peisert, who was promoted to President and Chief Executive Officer on December 14, 2020, stepped down from his roles as Chief Financial Officer (Principal Financial Officer) and Principal Accounting Officer.
There are no arrangements or understandings between Mr. Schwichtenberg and any other persons pursuant to which he was selected as Chief Financial Officer. There are also no family relationships between Mr. Schwichtenberg and any director or executive officer of the Company and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
There are no arrangements or understandings between Mr. Patel and any other persons pursuant to which he was selected as Chief Accounting Officer. There are also no family relationships between Mr. Patel and any director or executive officer of the Company and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|ASSERTIO HOLDINGS, INC.|
|Date: March 17, 2021||By:||/s/ Daniel A. Peisert|
|Daniel A. Peisert|
|President and Chief Executive Officer|